SCHEMBL429598

SCHEMBL429598

CCCCCCCCCCCCC(C)N(C(C)O)C(C)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 2/20 0.48
GPR84 Q9NQS5 5/20 0.43
FFAR1 O14842 1/20 0.43
LMNA P02545 2/20 0.43
OPRM1 P35372 1/20 0.41
CYP2D6 P10635 2/20 0.41
ADH1B P00325 1/20 0.41
ADH1C P00326 1/20 0.41
ADH1A P07327 1/20 0.41
ADH4 P08319 1/20 0.41
ADH7 P40394 1/20 0.41
GMNN O75496 1/20 0.41
POLB P06746 1/20 0.41
THPO P40225 1/20 0.41
MTOR P42345 1/20 0.41
BLM P54132 1/20 0.41
KDM4E B2RXH2 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7782007 1.00 SPHK1 (0.48) SPHK1GPR84FFAR1LMNAOPRM1
Hydrochloric Acid SCHEMBL25291227 0.98 SPHK1 (0.47) SPHK1GPR84FFAR1LMNACYP2D6
SCHEMBL372660 0.85 OPRM1 (0.48) SPHK1LMNAOPRM1ADH1BADH1C
SCHEMBL372503 0.85 OPRM1 (0.48) SPHK1LMNAOPRM1ADH1BADH1C
SCHEMBL372446 0.85 OPRM1 (0.48) SPHK1LMNAOPRM1ADH1BADH1C
SCHEMBL372363 0.85 OPRM1 (0.48) SPHK1LMNAOPRM1ADH1BADH1C
Hydrochloric Acid SCHEMBL6234785 0.83 OPRM1 (0.46) SPHK1LMNAOPRM1ADH1BADH1C
Bromide SCHEMBL11336578 0.83 OPRM1 (0.46) SPHK1LMNAOPRM1ADH1BADH1C
Bromide SCHEMBL11332379 0.83 OPRM1 (0.46) SPHK1LMNAOPRM1ADH1BADH1C
Water SCHEMBL11794021 0.83 OPRM1 (0.46) SPHK1LMNAOPRM1ADH1BADH1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2069470-B1 STRUCTURED SURFACTANT SYSTEM SOLVAY USA INC (US) 2021-03-24 EP disclosed
WO-2019109243-A1 Cosmetic composition for permanently changing the shape of keratinous fibers HENKEL AG & CO.KGAA (DE) 2019-06-13 WO disclosed
EP-3134182-A1 METHOD OF INHIBITING COPPER DEPOSITION ON HAIR The Procter & Gamble Company (US) 2017-03-01 EP disclosed
EP-2393469-B1 Process of treating hair RHODIA OPERATIONS (FR) 2016-10-12 EP disclosed
EP-2419077-B1 PROCESS OF TREATING DAMAGED HAIR RHODIA OPERATIONS (FR) 2016-10-12 EP disclosed
US-9187716-B2 Structured surfactant system RHODIA OPERATIONS (FR) 2015-11-17 US disclosed
WO-2015164137-A1 METHOD OF INHIBITING COPPER DEPOSITION ON HAIR THE PROCTER & GAMBLE COMPANY (US) 2015-10-29 WO disclosed
WO-2015164139-A1 METHOD OF INHIBITING COPPER DEPOSITION ON HAIR THE PROCTER & GAMBLE COMPANY (US) 2015-10-29 WO disclosed
US-20140308227-A1 PROCESS OF TREATING DAMAGED HAIR RHODIA OPERATIONS (FR) 2014-10-16 US disclosed
US-8828364-B2 Structured surfactant compositions RHODIA OPERATIONS (FR) 2014-09-09 US disclosed
WO-2008118381-A1 STRUCTURED SURFACTANT COMPOSITIONS RHODIA INC. (US) 2008-10-02 WO disclosed
US-20080233061-A1 Alkyl ether sulfate surfactant, alkyl sulfate surfactant, alkanolamide surfactant,amphoteric surfactant, and electrolyte; opacity, yield strength; sodium trideceth sulfate, sodium lauryl sulfate, ammonium lauryl sulfate, sodium lauroamphoacetate, coco monoethanolamide, ammonium chloride, citric acid SPECIALTY OPERATIONS FRANCE (FR) 2008-09-25 US disclosed
US-20080095733-A1 Structured surfactant system RHODIA OPERATIONS (FR) 2008-04-24 US disclosed
WO-2008039440-A1 STRUCTURED SURFACTANT SYSTEM RHODIA INC. (US) 2008-04-03 WO disclosed
CN-1315028-C Position Chinese character inputting method LI JIANXUE (CN) 2007-05-09 CN disclosed
CN-1886126-A Methods and products which utilize N-acyl-L-aspartic acid DMI BIOSCIENCES INC (US) 2006-12-27 CN disclosed
CN-1809593-A Galactomannan hydrocolloids NOVEON IP HOLDINGS CORP (US) 2006-07-26 CN disclosed
EP-1656106-A1 CLEAR PERSONAL CARE COMPOSITIONS CONTAINING A CATIONIC CONDITIONING POLYMER AND AN ANIONIC SURFACTANT SYSTEM THE PROCTER & GAMBLE COMPANY (US) 2006-05-17 EP disclosed
CN-1235617-C Containing magnesium ascorbyl phosphate and UNINONTAN-U34TMSkin whitening composition (preparation containing cucumber extract and lemon extract) MARY KAY INC (US) 2006-01-11 CN disclosed
WO-2004105723-A1 CLEAR PERSONAL CARE COMPOSITIONS CONTAINING A CATIONIC CONDITIONING POLYMER AND AN ANIONIC SURFACTANT SYSTEM THE PROCTER & GAMBLE COMPANY (US) 2004-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080233061-A1 Alkyl ether sulfate surfactant, alkyl sulfate surfactant, alkanolamide surfactant,amphoteric surfactant, and electrolyte; opacity, yield strength; sodium trideceth sulfate, sodium lauryl sulfate, ammonium lauryl sulfate, sodium lauroamphoacetate, coco monoethanolamide, ammonium chloride, citric acid SGMS2, SGMS1, ACMSD SPHK1 388/4885GPR84 264/4885FFAR1 203/4885
US-20080095733-A1 Structured surfactant system TTR, SPAST, SMURF1 SPHK1 747/4885GPR84 1941/4885FFAR1 2387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.